Raymond W. Cohen - 26 Mar 2026 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: Director
Issuer ticker: KMTS
Reported as of: 26 Mar 2026
Net transaction value: +$199,800
SEC form: 4
Accepted by SEC: 30 Mar 2026, 18:06:15 UTC
Prior SEC filing: 16 Jan 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Traci S. Umberger as attorney-in-fact for Raymond W. Cohen

Key filing fact

Raymond W. Cohen filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 30 Mar 2026.

Key facts

This page summarizes Raymond W. Cohen's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Mar 2026, 18:06.

Change

Previous filing in this sequence was filed on 16 Jan 2026.
Current net transaction value: +$199,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258288 Primary reporting owner

COHEN RAYMOND W

Relationship: Director
Address: C/O KESTRA MEDICAL TECHNOLOGIES LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND
Signature: /s/ Traci S. Umberger as attorney-in-fact for Raymond W. Cohen
Signature date: 30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Purchase

Transaction value: $199,800
Shares: +10,000
Change %: +24%
Price: $19.98
Shares after: 50,903
Date: 26 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $19.82 to $20.02. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.